Prognostic, diagnostic, and cancer therapeutic uses of fanci...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) C12N 5/078 (2010.01) C07K 14/47 (2006.01) C07K 19/00 (2006.01) C12N 15/11 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/567 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2680549

Disclosed herein are methods and compositions for the treatment of cancer. In particular, the present invention identifies and characterizes the FANCI polypeptide as a vital component of the Fanconi anemia pathway and discloses inhibitors of FANCI and methods of using same. Such inhibitors are useful in inhibiting DNA damage repair and can be useful, for example, in the treatment of cancer.

Cette invention se rapporte à des procédés et des compositions utilisés dans le traitement du cancer. En particulier, l'invention repère et caractérise le polypeptide FANCI comme composant vital des voies de l'anémie de Fanconi, et décrit des inhibiteurs de FANCI et des procédés d'utilisation de ceux-ci. Ces inhibiteurs sont utilisés pour inhiber les altérations de l'ADN et peuvent être utilisés, par exemple, dans le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prognostic, diagnostic, and cancer therapeutic uses of fanci... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prognostic, diagnostic, and cancer therapeutic uses of fanci..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognostic, diagnostic, and cancer therapeutic uses of fanci... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1726236

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.